Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

Payment Parity for Telehealth Linked to Better BP Treatment

Michael O'Riordan

August 07, 2024

News Daily News

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Michael O'Riordan

July 29, 2024

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

News Daily News

USPSTF Reaffirms Earlier Stance on Hypertension Screening in Adults

L.A. McKeown

April 28, 2021

News Daily News

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Michael O'Riordan

October 18, 2019

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Daily News

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

L.A. McKeown

April 09, 2019

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Shelley Wood

August 15, 2018

News Daily News

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Michael O'Riordan

January 30, 2018

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Payment Parity for Telehealth Linked to Better BP Treatment

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

FDA Issues New Guidance on Sodium Targets for Food Industry

USPSTF Reaffirms Earlier Stance on Hypertension Screening in Adults

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content